Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008Archived
In this study, the authors have combined a household method and a school study design to assess VE against mumps as well as VE against mumps infectiousness by comparing secondary attack rates in households of vaccinated and unvaccinated cases.
Snijders B, van Lier E, de Kassteele J, Fanoy E, Ruijs W, Hulshof F et al. Vaccine, 2012 [Epub ahead of print] doi:10.1016/j.vaccine.2012.02.035
The investigation of vaccine preventable diseases (VPD) outbreaks should be encouraged as it is a great opportunity to improve our knowledge about vaccines, to identify reasons for vaccine failure, pockets of susceptible and reasons for non-vaccination, and to improve the control of VPD through vaccination.
Mumps: Burden of disease in FranceArchived
19 Dec 2012 - Mumps is not a notifiable disease in France, and this study provides useful information by combining different data sources. The current incidence of mumps is somewhat higher than the average European (9 versus 3.2 per 100 000 per year) and authors sugges
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for SeronegativityArchived
16 Aug 2012 - This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.